Net Cash Provided by (Used in) Financing Activities in USD of Nascent Biotech Inc. from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Nascent Biotech Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2013 to 2023.
  • Nascent Biotech Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Jun 2023 was $0, a 100% decline year-over-year.
  • Nascent Biotech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,386,000, a 26% decline from 2022.
  • Nascent Biotech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1,865,000.
  • Nascent Biotech Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $320,500, a 133% decline from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Nascent Biotech Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $0 -$395,000 -100% 01 Apr 2023 30 Jun 2023 10-Q 18 Aug 2023 2024 Q1
Q2 2022 $395,000 +$615,500 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023 2024 Q1
Q2 2021 $220,500 -$270,500 -541% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2023 Q1
Q2 2020 $50,000 +$48,929 +4569% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2022 Q1
Q2 2019 $1,071 -$111,965 -99% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2021 Q1
Q2 2018 $113,036 -$120,178 -52% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2019 Q1
Q2 2017 $233,214 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018 2019 Q1
Q2 2015 $500,000 +$395,000 +376% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2017 Q1
Q2 2014 $105,000 01 Apr 2014 30 Jun 2014 10-Q 30 Jul 2015 2016 Q1

Nascent Biotech Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,386,000 -$479,000 -26% 01 Apr 2023 31 Mar 2024 10-K 01 Jul 2024 2024 FY
2022 $1,865,000 +$2,185,500 01 Apr 2022 31 Mar 2023 10-K 01 Jul 2024 2024 FY
2021 $320,500 -$1,305,500 -133% 01 Apr 2021 31 Mar 2022 10-K/A 03 Jul 2023 2023 FY
2020 $985,000 +$558,929 +131% 01 Apr 2020 31 Mar 2021 10-K 15 Jun 2022 2022 FY
2019 $426,071 -$300,215 -41% 01 Apr 2019 31 Mar 2020 10-K 08 Jul 2021 2021 FY
2018 $726,286 -$485,283 -40% 01 Apr 2018 31 Mar 2019 10-K 22 Jun 2020 2020 FY
2017 $1,211,569 +$886,269 +272% 01 Apr 2017 31 Mar 2018 10-K 12 Jul 2019 2019 FY
2016 $325,300 -$310,900 -49% 01 Apr 2016 31 Mar 2017 10-K 29 Jun 2018 2018 FY
2015 $636,200 -$658,800 -51% 01 Apr 2015 31 Mar 2016 10-K 29 Jun 2017 2017 FY
2014 $1,295,000 +$1,131,932 +694% 01 Apr 2014 31 Mar 2015 10-K 14 Jul 2016 2016 FY
2013 $163,068 01 Apr 2013 31 Mar 2014 10-K 02 Jul 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.